Efficacy of rezafungin in a case of Candida spondylodiskitis
Language
EN
Article de revue
This item was published in
Journal of Bone and Joint Infection. 2024-01-01, vol. 9, n° 5, p. 213-215
English Abstract
Rezafungin, which only requires weekly administration, is a potential candidate for difficult-to-treat infections that require long-term antimicrobial treatment, such as bone and joint infections. We report the first case ...Read more >
Rezafungin, which only requires weekly administration, is a potential candidate for difficult-to-treat infections that require long-term antimicrobial treatment, such as bone and joint infections. We report the first case of spondylodiskitis successfully treated with 3 weeks of caspofungin followed by 10 weeks of rezafungin.Read less <